NIH UPDATE: Notice of Fiscal Policies in Effect for FY 2024

Notice of Fiscal Policies in Effect for FY 2024

Notice Number: NOT-OD-24-109

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-24-109.html

Purpose:

This Notice provides guidance about the NIH Fiscal Operations for Fiscal Year 2024 and implements the Further Consolidated Appropriations Act, 2024 (Public Law 118-47), signed into law on March 23, 2024.

FY 2024 Funding Levels: Non-competing continuation awards made in FY 2024 will generally be issued at the commitment level indicated on the Notice of Award with exceptions posted on the NIH Funding Strategies webpage. Subsequent budget periods are funded based on the availability of appropriations, satisfactory performance, compliance with the terms and conditions of the award, and the continued best interest of the Federal government. The NIH awarding Institutes/Centers (ICs) will develop and post their fiscal policies consistent with overall NIH goals and available FY 2024 funds.

Ruth L. Kirschstein National Research Service Awards (NRSA): Consistent with the recommendations of the Advisory Committee to the Director regarding the Biomedical Research Workforce, the NIH will increase NRSA stipends by approximately four percent for predocs and eight percent for postdocs. The full range of stipend adjustments for FY 2024 is described in NIH Guide Notice NOT-OD-24-104.

Salary Limits: Section 202 of PL 118-47 restricts the amount of direct salary to Executive Level II of the Federal Executive pay scale. Effective January 1, 2024, the salary limitation for Executive Level II is $221,900. Further information is described in NIH Guide Notice  NOT-OD-24-057.

Additional Information: Additional details on Fiscal Operations, including specific funding strategies for ICs, will be posted on the NIH Funding Strategies webpage.

 

Please refer to the full notice linked above for further details.

 

Should you have any questions, please contact the Office of Sponsored Programs.